瑞典全国性研究:类风湿关节炎持续缓解的长期趋势
该研究纳入瑞典风湿病质量登记中至2012年登记的29 084例成人RA患者,分析达到持续缓解(DAS28<2.6至少连续两次且持续至少6个月)的长期趋势。结果显示,症状起始于1980年代、1990年代和2000年代的患者中分别有35.0%、43.0%和45.6%达到持续缓解(每十年递增P<0.001)。结论认为瑞典RA患者持续缓解发生率呈明显年代递增趋势,可能反映更早诊断、更早治疗及遵循靶向治疗指南。
要点
- 症状起始于1980、1990、2000年代的患者持续缓解率分别为35.0%、43.0%、45.6%。
- 每一年代持续缓解的 odds 均高于前一年代,1994至2009年每年 hazard ratio 为1.15(95%CI 1.14, 1.15)。
- 2009年症状起始后5年45.3%患者达到持续缓解,而1999年为15.9%。
核心结论
- 瑞典RA患者达到持续缓解的发生率呈明显年代递增趋势。
- 该趋势最可能反映更早诊断和治疗启动,以及遵循国家和国际指南推荐的靶向治疗策略。
研究设计与样本
- 基于瑞典风湿病质量登记至2012年登记的成人RA患者,共29 084例,至少3次登记访视。
- 症状起始年份范围自1955年起,部分分析仅纳入症状起始于1994至2009年的患者。
- 95%患者满足ACR 1987年RA分类标准。
- 采用逻辑回归计算每十年相对前十年达到持续缓解的 odds,并采用生命表分析比较各症状起始年份。
主要发现
- 症状起始于1980年代、1990年代和2000年代的患者中,达到持续缓解的比例分别为35.0%、43.0%和45.6%(每十年递增P<0.001)。
- 每一年代达到持续缓解的 odds 均高于前一年代。
- 1994至2009年间,每一年相对前一年达到持续缓解的 hazard ratio 为1.15(95%CI 1.14, 1.15)。
- 2009年症状起始后5年,45.3%患者达到持续缓解,而1999年症状起始后5年该比例为15.9%。
关键数值与推荐
- 持续缓解定义为DAS28<2.6至少连续两次且持续至少6个月。
临床怎么用
- 结果支持对RA患者遵循靶向治疗策略以实现持续缓解。
- 更早诊断和治疗启动可能与持续缓解率提高相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of this study of patients with RA in Sweden was to investigate secular trends in achieving sustained remission (SR), i.e. DAS28 <2.6 on at least two consecutive occasions and lasting for at least 6 months. METHODS: All adult RA patients registered in the Swedish Rheumatology Quality register through 2012, with at least three registered visits were eligible, a total of 29 084 patients. Year of symptom onset ranged from 1955, but for parts of the analysis only patients with symptom onset between 1994 and 2009 were studied. In total, 95% of patients fulfilled the ACR 1987 classification criteria for RA. Odds of reaching SR for each decade compared with the one before were calculated with logistic regression and individual years of symptom onset were compared with life table analysis. RESULTS: Of patients with symptom onset in the 1980s, 1990s and 2000s, 35.0, 43.0 and 45.6% reached SR, respectively (P < 0.001 for each increment), and the odds of SR were higher in every decade compared with the one before. The hazard ratio for reaching SR was 1.15 (95% CI 1.14, 1.15) for each year from 1994 to 2009 compared with the year before. Five years after symptom onset in 2009, 45.3% of patients had reached SR compared with 15.9% in 1999. CONCLUSION: There is a clear secular trend towards increased incidence of SR in patients with RA in Sweden. This trend most likely reflects earlier diagnosis and treatment start, and adherence to national and international guidelines recommending the treat to target approach.
引用
- Einarsson JT, Willim M, Saxne T, et al. Secular trends of sustained remission in rheumatoid arthritis, a nationwide study in Sweden. Rheumatology (Oxford). 2020. PMID: 31302705. doi:10.1093/rheumatology/kez273
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。